C4 Therapeutics, Inc. (CCCC) Stock buybacks 2019–2025
C4 Therapeutics, Inc. (CCCC) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$193,000FY2025 · since FY2019: $30,000 → $193,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $193,000 | -0.5% |
| FY2024 | $194,000 | +76.4% |
| FY2023 | $110,000 | — |
| FY2022 | $0 | — |
| FY2020 | $194,000 | +546.7% |
| FY2019 | $30,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CCCC financial trends
CCCC RevenueCCCC Net incomeCCCC Net marginCCCC Gross profitCCCC Gross marginCCCC Operating incomeCCCC Operating marginCCCC Operating cash flowCCCC Free cash flowCCCC Capital expendituresCCCC Return on equityCCCC Dividends paidCCCC Total assetsCCCC Total liabilitiesCCCC Shareholders’ equityCCCC overview →